Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: Randomized Phase IIb Trial of DVC1-0101 [Phase 2]

View source ↗

Summary

A randomized Phase IIb trial update for DVC1-0101 in intermittent claudication and peripheral arterial disease is reported, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DVC1-0101

Snippet

Sponsor: Kyushu University | Conditions: Intermittent Claudication, Peripheral Arterial Disease | Phase 2 | Status: UNKNOWN